This Week In Huntington's Disease Research keeps you up-to-date on HDSA research activities, recently published work about Huntington’s disease, historical moments in HD research and more.

Happy Holidays from HDSA: Research Wrap-Up, Online Surveys & More

Posted on December 22, 2022

Happy Holidays from HDSA   Despite 2022’s ups and downs in HD research, HDSA has found plenty to celebrate, especially all…

Read More

HDBuzz, STAT News, Ask the Scientists, & More 

Posted on December 15, 2022

HDBuzz Covers Latest Update from Novartis   Last week, Novartis shared that they will end development of branaplam for HD. Dosing of…

Read More

HDBuzz on Novartis, HDSA Research Webinar, STAT News on HD Research, Online Survey

Posted on

HDBuzz Covers Latest Update from Novartis   Last week, Novartis shared that they will end development of branaplam for HD….

Read More

Novartis Shares Update on VIBRANT-HD, Ask the Scientists…Anything, and Launch of HDSA Research Fellowship Applications

Posted on December 8, 2022

Novartis Shares Update on VIBRANT-HD   Today Novartis shared that they will end development of branaplam for HD. This difficult news…

Read More

Thank You Thursday, HD-ISS, and Gene Therapy 101

Posted on December 1, 2022

Happy Thank You Thursday from HDSA   Support from HD families like you is what allows HDSA to fight for a…

Read More

Celebrate #GivingTuesday with HDSA

Posted on November 17, 2022

At HDSA, we’re grateful for your commitment to HDSA’s vision of a world free of Huntington’s disease and for your…

Read More

Highlights from HSG’s 2022 Annual Meeting, Interview Study, and Genetic Counselor Awareness Day

Posted on November 10, 2022

Highlights from HSG’s Annual Meeting 2022  Last weekend, clinicians, researchers, and industry partners from around the world assembled in Tampa,…

Read More

HDSA Research Awards, Clinical Trials Updates & HD Podcasts

Posted on November 3, 2022

HDSA Awards Six Huntington’s Disease Human Biology Project Research Fellowships for 2022  After thoughtful deliberation by its Scientific Advisory Board,…

Read More

HDSA Research Webinar, HD Care, & HD History

Posted on October 27, 2022

HDSA Research Webinar: Update from PTC Therapeutics on the PIVOT-HD Trial  Last week, PTC Therapeutics shared that its Phase 2…

Read More

Clinical Trial News & New Online Survey

Posted on October 20, 2022

PTC Therapeutics provides enrollment update  PTC Therapeutics shared a press release this week to confirm that enrollment is active and…

Read More

HDSA Surveys & Support the HD Parity Act!

Posted on October 13, 2022

Participate in HDSA-Vetted Research Surveys  Researchers, clinicians, healthcare professionals, and students studying HD frequently design surveys to get input from…

Read More

This Week’s Blog: 10.6.2022

Posted on October 6, 2022

HDBuzz on ASO headlines: What’s the latest on huntingtin-lowering?   Recent weeks have brought news for familiar players in the…

Read More

This Week’s Blog: 9.29.22

Posted on September 29, 2022

Summer Research Recap   This summer was full of ups and downs in HD research. Following a research webinar in August that recapped challenging clinical trials…

Read More

This Week’s Blog: 9.22.22

Posted on September 22, 2022

Wave Life Sciences announces positive results from SELECT-HD  Earlier this week, Wave Life Sciences shared a positive update from the…

Read More

Celebrate HDSA Founder’s Day on September 18th

Posted on September 15, 2022

55 years ago, Marjorie Guthrie sought out volunteers from across the country and created the first network of support for…

Read More

HDSA Research Webinar Recording: All you need to know about PROOF-HD

Posted on September 8, 2022

This week HDSA hosted a research webinar in which Dr. Michael Hayden, CEO of Prilenia, and clinical leads Drs. Andy…

Read More

HDSA webinar Sept 7th: All you Need to Know About PROOF-HD

Posted on September 1, 2022

In its Phase III trial, PROOF-HD, Prilenia is currently studying the effects of pridopidine on total functional capacity in people with HD. On…

Read More

Novartis releases community update on VIBRANT-HD

Posted on August 25, 2022

This week, Novartis released a community update on VIBRANT-HD, the phase 2b study of branaplam in adults with HD. The statement…

Read More

HDSA Centers of Excellence program now accepting LOI’s for 2023 designation  

Posted on August 18, 2022

HDSA Centers of Excellence program now accepting LOI’s for 2023 designation   HDSA’s Centers of Excellence (COE) Program is the…

Read More

#LetsTalkAboutHD Clinical Trials

Posted on August 11, 2022

Multiple pieces of news about ongoing clinical trials were shared this week by companies developing therapies for HD. We discuss…

Read More